The ultimate cure for COVID-19 has not yet been discovered, but there is a lot of promoted traditional and food supplements claimed to be effective against the disease. Some of the promoted measures are not only associated with other adverse health outcome, but also create a sense of false protection; leading to failure to follow appropriate measures. It is crucial to identify, correct this misinformation, and to conduct clinical trials to generate evidence among those which are scientifically sound.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796843 | PMC |
| http://dx.doi.org/10.11604/pamj.supp.2020.37.29.25547 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The role of randomized controlled trials, registries, observational databases in evaluating new interventions.
Best Pract Res Clin Haematol
December 2023
Case Western Reserve University, Cleveland, OH, USA.
Approaches to comparing safety and efficacy of interventions include analyzing data from randomized controlled trials (RCTs), registries and observational databases (ODBs). RCTs are regarded as the gold standard but data from such trials are sometimes unavailable because a disease is uncommon, because the intervention is uncommon, because of structural limitations or because randomization cannot be done for practical or (seemingly) ethical reasons. There are many examples of an unproved intervention being so widely-believed to be effective that clinical trialists and potential subjects decline randomization.
View Article and Find Full Text PDFIn Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from .
Int J Mol Sci
August 2023
Department of Microbiology, School of Medicine, Kansai Medical University, 2-5-1 Shinmachi, Hirakata 573-1010, Japan.
Article Synopsis
- This study investigated how outer-membrane vesicles (OMVs) from oral bacteria influence the degeneration of neuroblastoma cells, specifically using in situ Raman spectroscopy to track metabolomic changes.
- OMVs are associated with Alzheimer's disease (AD) as they deliver harmful toxins that can damage neurons, but the exact chemical processes involved are not well understood.
- The research revealed important chemical signatures and mechanisms related to neuronal degradation, including the roles of lipopolysaccharides and proteins involved in forming amyloid plaques and Tau tangles that worsen AD symptoms.
Promotion of unproved and potential dangerous measures in fighting COVID-19 pandemic: urgent need for vigilant appropriate public communication and generation of scientific evidence.
Pan Afr Med J
February 2021
Hubert Kairuki Memorial University, Department of Pediatrics and Child Health, Dar es Salaam, Tanzania.
The ultimate cure for COVID-19 has not yet been discovered, but there is a lot of promoted traditional and food supplements claimed to be effective against the disease. Some of the promoted measures are not only associated with other adverse health outcome, but also create a sense of false protection; leading to failure to follow appropriate measures. It is crucial to identify, correct this misinformation, and to conduct clinical trials to generate evidence among those which are scientifically sound.
View Article and Find Full Text PDFFor half a century, the dominant paradigm in psychotherapy research has been to develop syndrome-specific treatment protocols for hypothesized but unproved latent disease entities, as defined by psychiatric nosological systems. While this approach provided a common language for mental health problems, it failed to achieve its ultimate goal of conceptual and treatment utility. Process-based therapy (PBT) offers an alternative approach to understanding and treating psychological problems, and promoting human prosperity.
View Article and Find Full Text PDFStandardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System.
Am Health Drug Benefits
April 2018
Professor of Medicine, Harborview Medical Center, University of Washington School of Medicine.
Background: As healthcare costs rise and reimbursements decrease, healthcare organization leadership and clinical providers must collaborate to provide high-value healthcare. Medications are a key driver of the increasing cost of healthcare, largely as a result of the proliferation of expensive specialty drugs, including biologic agents. Such medications contribute significantly to the inpatient diagnosis-related group payment system, often with minimal or unproved benefit over less-expensive therapies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!